Experimental model of autoimmune myosin-induced myocardium injury

Biopolymers and Cell

Volumn 23, Issue 2, 2007, Pages 115-121

  Bobyk, V I ^a   Ryabenko, D V ^b   Sergienko, O V ^b   Trunina, I V ^b   Fedorkova, O M ^a   Morozova, L M ^a   Sidorik, L L ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b Ukranian Strazhesko Institute of Cardiology   (Ukraine)

Author keywords

Autoantibodies; Dilated cardiomyopathy; Myo cardial damage; Myosin

Indexed keywords

EID: 65949122436     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.00075D     Document Type: Article

References (22)

1. Keeling P. J., Tracy S. Link between enteroviruses and dilated cardiomyopathy: serological and molecular data // Br. Heart J.-1994.-72 (suppl. S).-S. 25-29.
2. Dale J. B., Beachey E. H. Sequence of myosin-cross-reactive epitopes of streptococcal M protein // J. Exp. Med.-1986.-164.-P. 1785-1790.
3. Cunha-Neto E., Duranti M., Gruber A., Zingales B., Messias I., Stolf N., Bellotti J., Pattaroyo M. E., Pilleggi F., Kalil J. Autoimmunity in phagas disease cardiomyopathy: biological relevance of a cardiac myosin-specific epitope cross-reactive to an immunodominant trypanosoma cruzi antigen // Proc. Nat. Acad. Sci. USA.-1995.-92.-P. 3541-3545.
4. McCall D. Alcohol and the heart // Curr. Problems. Cardiol.-1987.-27.-P. 351-408.
5. Staudt A., Schaper F., Stangl V., Plagemann A., Bohm M. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorbtion therapy and subsequent immunoglobulin substitution // Circulation.-2001.-103.-P. 268-286.
6. Rose N. R., Hill S. L. Autoimmune myocarditis // Int. J. Cardiol.-1996.-54.-P. 171-175.
7. Li Z., Menoret A., Srivastava P. Roles of heat shock proteins in antigen presentation and cross-presentation // Curr. Opin. Immunol.-2002.-14.-P. 45-51.
8. Portig I., Pankuwelt S., Maisch B. Antibodies against stress proteins in sera of patients with dilated cardiomyopathy // J. Mol. Cell Cardiol.-1997.-29.-P. 2245-2251.
9. Fink A. I. Chaperon-mediated protein folding // Physiol. Revs.-1999.-79.-P. 185-192.
10. Apoptosis, and myocardial injury // Circulation.-2002.-105.-P. 2899-2904.
11. Arber S., Hunter J. J., Ross J., Hongo M., Sansig G., Borg J., Perriard J. C., Chlen K. R., Caroni H. MLP-deficiant mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure // Cell.-1997.-88.-P. 393-403.
12. Margossian S. Reversible dissotiation of dog cardiac myosin regulatory light chain 2 and its influence on ATP hydrolysis // J. Biol. Chem.-1985.-260.-P. 13747-13754.
13. Laemmli U. Cleavage of structural proteins during the assembly of the bacteriophage T4 // Nature.-1970.-227.-P. 680-685.
14. Matsiota P., Druet P., Dosquet P. Natural autoantibodies in systemic lupus erythematosus // Clin. Exp. Immunol.-1987.-69.-P. 79-88.
15. Bradford M. A rapid and sensitive method for quantitation and microgramm quantities of protein utilizing the principle of protein binding // Anal. Biochem.-1976.-72.-P. 193-200.
16. Kodama T., Fukui K., Kometani K. The initial phosphate bust in ATP hydrolysis by myosin and subfragment as studied by a modified malachite green method for determination of inorganic phosphate // J. Biochem.-1986.-99.-P. 1465-1472.
17. Mize R. R. Quantitative image analysis for immunocytochemistry and in situ hybridization // Neurosci. Meth. J.-1994.-54.-P. 219-237.
18. Rose N., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited) // Immunol. Today.-1993.-14.-P.
19. Caforio A. L. P., Bonifacio E., Stewart J. T., Neglia D., Parodi O., Bottazzo J. F., McKenna W. J. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy // J. Amer. Chem. Soc.-1990.-15.-P. 1527-1534.
20. Hein S., Schaper J. The pathogenesis of dilated cardiomyopathy and heart failure: insights from cell morphology and biology // Curr. Opin. Cardiol.-1996.-11.-P. 293-301.
21. Caforio A. L. P., Bonifacio E., Stewart J. T., Neglia D., Parodi O., Bottazzo J. F., McKenna W. J. Identification of a-and b-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy // Circulation.-1992.-85.-P. 1734-1742.
22. Caforio A. L. P., Goldman J. H., Baig M. K., Haven A. J., Libera L. D., Keeling P. J., McKenna W. J. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression // Heart.-1997.-77.-P. 62-67.